Zobrazeno 1 - 5
of 5
pro vyhledávání: '"MESH: Erythrocyte Count"'
Autor:
Adiogo, Andréa
Publikováno v:
Médecine humaine et pathologie. 2018
Introduction: out of the ABO system, alloimmunization in pregnancy affects approximately 1/1000 births. Anti-D (RH1), anti-K (KEL1), and anti-c (RH4) are responsible for the majority of severe forms that develop before birth. The implementation of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::431e5a00a6779dc044a59477eeb252ca
https://dumas.ccsd.cnrs.fr/dumas-02071833/file/ThExe_ADIOGO_Andrea_DUMAS.pdf
https://dumas.ccsd.cnrs.fr/dumas-02071833/file/ThExe_ADIOGO_Andrea_DUMAS.pdf
Autor:
Miguel Bento Ricardo, Irene Aragão, Etienne Gayat, Pedro Bettencourt Medeiros, Faiez Zannad, Heli Tolppanen, Alexandre Rola, João Pedro Ferreira, Christian Mueller, Mattia Arrigo, Patrick Rossignol, Nicolas Girerd, Said Laribi, Alexandre Mebazaa, Tiago Almeida
Publikováno v:
Medicine
Medicine, Lippincott, Williams & Wilkins, 2016, 95 (14), pp.e3307. ⟨10.1097/MD.0000000000003307⟩
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Medicine, Lippincott, Williams & Wilkins, 2016, 95 (14), pp.e3307. ⟨10.1097/MD.0000000000003307⟩
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Supplemental Digital Content is available in the text
Red blood cell distribution width (RDW) may serve as an integrative marker of pathological processes that portend worse prognosis in heart failure (HF). The prognostic value of RDW variation
Red blood cell distribution width (RDW) may serve as an integrative marker of pathological processes that portend worse prognosis in heart failure (HF). The prognostic value of RDW variation
Autor:
Monique Duvareille, Stéphane Blanc, Guido Ferretti, Guillemette Gauquelin-Koch, Natacha Pellet, Marc Antoine Custaud, Eric J. Belin de Chantemèle, Claude Gharib
Publikováno v:
European Journal of Applied Physiology, Vol. 92, No 4-5 (2004) pp. 555-564
Arbeitsphysiologie
Arbeitsphysiologie, Berlin ; Göttingen ; Heidelberg : Springer, 2004, 92 (4-5), pp.555-564. ⟨10.1007/s00421-004-1121-6⟩
Arbeitsphysiologie
Arbeitsphysiologie, Berlin ; Göttingen ; Heidelberg : Springer, 2004, 92 (4-5), pp.555-564. ⟨10.1007/s00421-004-1121-6⟩
National audience; Although various exercise regimens are commonly used as countermeasures to reduce the cardiovascular deconditioning induced by microgravity, the underlying mechanisms are not well understood. In this study we aimed to test whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93ee0bb7d804acbb37f11eaa9ee949c3
https://archive-ouverte.unige.ch/unige:10181
https://archive-ouverte.unige.ch/unige:10181
Autor:
Daniel Lambert, Anne Ponthieux, Suzanne Droesch, Sophie Visvikis, Nadia Haddy, Bernard Herbeth
Publikováno v:
Atherosclerosis
Atherosclerosis, Elsevier, 2004, 172 (2), pp.299-308. ⟨10.1016/j.atherosclerosis.2003.11.003⟩
Atherosclerosis, 2004, 172 (2), pp.299-308. ⟨10.1016/j.atherosclerosis.2003.11.003⟩
Atherosclerosis, Elsevier, 2004, 172 (2), pp.299-308. ⟨10.1016/j.atherosclerosis.2003.11.003⟩
Atherosclerosis, 2004, 172 (2), pp.299-308. ⟨10.1016/j.atherosclerosis.2003.11.003⟩
Background: Circulating levels of adhesion molecules increase in various inflammation-related diseases, such as atherosclerosis. However, data about factors influencing their concentrations in physiological conditions are scarce. Methods: We have stu
Autor:
C. Vedrinne, C.C. Arvieux, G Hadour, E. Cannet, J.J. Lehot, R. Forrat, Laurent Sebbag, René Ferrera, J. Guidollet, M de Lorgeril
Publikováno v:
HAL
Journal of Cardiovascular Pharmacology
Journal of Cardiovascular Pharmacology, Lippincott, Williams & Wilkins, 1996, 28 (4), pp.500-6
Journal of Cardiovascular Pharmacology
Journal of Cardiovascular Pharmacology, Lippincott, Williams & Wilkins, 1996, 28 (4), pp.500-6
International audience; Trimetazidine (TMZ) has been described as a new antiischemic agent. Whereas its precise mechanism of action remains unknown, antioxidant properties and the ability to preserve high-energy phosphate metabolism have been reporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e66508b2d9bc16ce5c6f54a0a429295f
https://hal.archives-ouvertes.fr/hal-00395740
https://hal.archives-ouvertes.fr/hal-00395740